Country

Clinical trials in New Zealand

Active obesity and GLP-1 studies with at least one location in New Zealand.

9active studies

5recruiting now

10countries represented

121largest site network

Current studies

Status and location data reflect the registry snapshot built 2026-09-08. Verify the original record before contacting a site.

Recruiting nowPhase 3

A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar

Type 2 DiabetesCondition

Placebo, SurvodutideTreatment

Australia, Canada121 locations

Boehringer IngelheimSponsor

Updated 2026-09-03 · NCT07754461See eligibility →

Recruiting nowPhase 2

A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or Overweight

Obesity, OverweightCondition

BI 3034701, Placebo matching BI 3034701Treatment

Australia, Canada54 locations

Boehringer IngelheimSponsor

Updated 2026-09-03 · NCT07662122See eligibility →

Recruiting nowPhase 1, Phase 2

A First-In-Human Study of ARO-INHBE in Adults With Obesity With and Without Type 2 Diabetes Mellitus

ObesityCondition

ARO-INHBE, PlaceboTreatment

Australia, New Zealand7 locations

Arrowhead PharmaceuticalsSponsor

Updated 2026-08-18 · NCT06700538See eligibility →

Recruiting nowPhase 1, Phase 2

A First-In-Human Study of ARO-ALK7 in Adults With Obesity With and Without Type 2 Diabetes Mellitus

Obesity, Diabetes Mellitus, Type 2Condition

ARO-ALK7, PlaceboTreatment

Australia, New Zealand8 locations

Arrowhead PharmaceuticalsSponsor

Updated 2026-07-08 · NCT06937203See eligibility →

Recruiting nowNot applicable

Assessment of Breathing Pattern During NIV

COPD (Chronic Obstructive Pulmonary Disease), Obesity Hypoventilation Syndrome (OHS)Condition

NIV mask A, NIV mask BTreatment

New Zealand1 locations

Fisher and Paykel HealthcareSponsor

Updated 2025-05-11 · NCT06682286See eligibility →

Opening soonPhase 2

Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese

Obesity and OverweightCondition

NA-931, TirzepatideTreatment

Australia, New Zealand17 locations

Biomed Industries, Inc.Sponsor

Updated 2026-03-27 · NCT06732245See eligibility →

Opening soonNot applicable

The Effect of Mask Design on Ventilation Parameters in COPD and OHS Patients on Long-term Home Non-invasive Ventilation. An Experimental Study.

COPD (Chronic Obstructive Pulmonary Disease), Obesity Hypoventilation Syndrome (OHS)Condition

Investigational Mask, Conventional maskTreatment

New Zealand1 locations

Fisher and Paykel HealthcareSponsor

Updated 2025-05-15 · NCT06972589See eligibility →

Active, not recruitingPhase 1

Phase 1/1b Study of TLC-6740 in Healthy Subjects and Subjects With Obesity, With or Without Diabetes

Healthy Subjects, ObesityCondition

TLC-6740 Oral Solution, Placebo Oral SolutionTreatment

New Zealand4 locations

OrsoBio, IncSponsor

Updated 2026-08-21 · NCT05822544See eligibility →

Active, not recruitingPhase 2

A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus

Overweight or Obese, Type 2 Diabetes Mellitus (T2DM)Condition

Placebo, EnicepatideTreatment

Argentina, Canada70 locations

Carmot Therapeutics, Inc.Sponsor

Updated 2026-06-24 · NCT06628362See eligibility →

Related countries

United States1,107 China326 Canada158 France110 Spain98 Germany95

How current is this page?

The page is rebuilt from the public registry feed. Each trial card shows the registry update date. Recruitment can still change between builds.

Does appearing here mean I qualify?

No. These pages are discovery indexes. Only a study team can confirm eligibility after reviewing the complete protocol criteria.